Glymphatic Function and White Matter Integrity in Cerebral Venous Disorders

Not yet recruitingOBSERVATIONAL
Enrollment

149

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

October 31, 2026

Conditions
Cerebral Venous Sinus Thrombosis
Interventions
OTHER

Baseline and 3-month follow-up

"At baseline and day 90 (±14) post-enrollment:~1. Collect clinical data;~2. Administer multiple scales to assess clinical symptom severity and neuropsychological status;~3. Perform cranial diffusion tensor imaging (DTI) to evaluate glymphatic function and white matter integrity;~4. Collect peripheral blood and cerebrospinal fluid (CSF) samples for biomarker level analysis."

OTHER

Baseline

"At baseline:~1. Collect clinical data;~2. Assess intracranial and extracranial arterial and venous systems;~3. Administer multiple scales to assess neuropsychological status;~4. Perform cranial diffusion tensor imaging (DTI) to evaluate glymphatic function and white matter integrity;~5. Collect peripheral blood samples for biomarker level analysis."

Trial Locations (1)

Unknown

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT07072663 - Glymphatic Function and White Matter Integrity in Cerebral Venous Disorders | Biotech Hunter | Biotech Hunter